Loading...
XSTO
ORTI B
Market cap6mUSD
May 28, Last price  
1.50SEK
1D
0.00%
1Q
-9.09%
Jan 2017
-36.03%
Name

Ortivus AB

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
0.41
EPS
—
Div Yield, %
—
Shrs. gr., 5y
2.64%
Rev. gr., 5y
9.60%
Revenues
80m
-4.36%
173,550,000199,776,000162,408,00083,113,000105,039,00047,726,00045,748,00060,710,00036,105,00069,366,00072,619,00074,279,00058,799,00052,200,00050,848,000107,582,00094,272,000104,509,00084,081,00080,413,000
Net income
-25m
L+36.49%
-17,713,000-149,186,000-61,289,000-68,946,000-18,480,000-22,271,000-37,860,0002,220,000-14,043,0001,400,000-7,090,000-7,079,000-11,605,000-13,391,000-16,580,00011,332,0009,211,0005,892,000-18,245,000-24,903,000
CFO
-10m
L+3,116.83%
-18,161,000-40,418,000-1,396,000-18,976,000-10,052,000-26,694,000-8,688,0008,946,000-7,128,00031,934,000-3,387,0004,935,000-11,898,000-510,000-3,510,00018,630,0007,774,000-6,878,000-303,000-9,747,000

Profile

Ortivus AB (publ) develops and commercializes medical technology solutions for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitors and measures the patient's vital parameters, such as ECG, blood pressure, and SpO2; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed Life, which is designed for advanced monitoring and resuscitation; and MobiMed Cloud that supports multiplatform data sharing on Windows, Webb, IOS, and Android. It also provides support, implementation, training, and consulting services. The company was incorporated in 1985 and is headquartered in Danderyd, Sweden.
URL
https://www.ortivus.com/
IPO date
Jan 02, 1997
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
80,413
-4.36%
84,081
-19.55%
104,509
10.86%
Cost of revenue
99,488
100,479
97,849
Unusual Expense (Income)
NOPBT
(19,075)
(16,398)
6,660
NOPBT Margin
6.37%
Operating Taxes
86
55
(79)
Tax Rate
NOPAT
(19,161)
(16,453)
6,739
Net income
(24,903)
36.49%
(18,245)
-409.66%
5,892
-36.03%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,385
1,907
2,056
Long-term debt
41,647
9,055
10,384
Deferred revenue
8,545
6,909
Other long-term liabilities
89
1,055
6,909
Net debt
36,751
5,673
4,843
Cash flow
Cash from operating activities
(9,747)
(303)
(6,878)
CAPEX
(423)
(6,093)
Cash from investing activities
(7,590)
(14,762)
(6,149)
Cash from financing activities
23,330
8,726
(1,490)
FCF
(17,228)
4,820
(10,125)
Balance
Cash
7,281
1,289
7,597
Long term investments
4,000
Excess cash
3,260
1,085
2,372
Stockholders' equity
(15,482)
2,648
Invested Capital
33,090
47,868
53,101
ROIC
12.33%
ROCE
13.71%
EV
Common stock shares outstanding
44,307
44,307
44,307
Price
1.39
-70.68%
4.74
-14.13%
5.52
6.15%
Market cap
61,587
-70.68%
210,017
-14.13%
244,577
6.15%
EV
98,338
215,690
249,420
EBITDA
(19,075)
(13,282)
9,168
EV/EBITDA
27.21
Interest
3,596
578
11
Interest/NOPBT
0.17%